semaglutide breast cancer GLP-1 medications may improve survival and reduce recurrence in patients, study finds. More details in comments GLP-1 Medications and Breast Cancer:

Contraindications Do Not Use If You Have a known hypersensitivity to NAD+ or any component of the formulation Are pregnant or breastfeeding (safety has not been established) Have active cancer (theoretical concerns about supporting rapidly dividing cells) Warnings and Precautions Rate of administration: Rapid administration is associated with more intense side effects including chest tightness, shortness of breath, flushing, and nausea

Barreiro-de Acosta, M

Retatrutide weight loss from Phase 2 and TRIUMPH-4 Retatrutide entered the clinical picture with a Phase 2 trial published in the New England Journal of Medicine

Hemodynamic assessment in heart failure with preserved ejection fraction